Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2023-02-02 00:00:00 ET · period of report 2023-01-31 · accession 0001654954-23-001225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-02 | 2023-01-31 | AEHR | Erickson Gayn | Pres, CEO, Dir | M - OptEx | $2.58 | +123.8K | 619.1K | +25% | +$319.2K |
| DM | 2023-02-02 | 2023-01-31 | AEHR | Erickson Gayn | Pres, CEO, Dir | M - OptEx | $0.00 | -123.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | M | A | 23,856 | $3.93 | 519,109 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-31 | M | A | 80,997 | $2.40 | 600,106 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-31 | M | A | 18,958 | $1.64 | 619,064 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| 4 | Derivative | Incentive Stock Option (right to buy) | 2023-01-31 | M | D | 18,958 | $0.00 | 16,251 | D | $1.64 · 2019-08-16 to 2026-07-16 | 18,958 Common Stock | (F2) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 5 | Derivative | Incentive Stock Option (right to buy) | 2023-01-31 | M | D | 80,997 | $0.00 | 0 | D | $2.40 · 2018-09-17 to 2025-08-17 | 80,997 Common Stock | (F2) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |
| 6 | Derivative | Incentive Stock Option (right to buy) | 2023-01-31 | M | D | 23,856 | $0.00 | 0 | D | $3.93 · 2017-08-11 to 2024-07-11 | 23,856 Common Stock | (F2) One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. |